FAQ: Calidi Biotherapeutics' Presentation at H.C. Wainwright Global Investment Conference

What is the main topic of this announcement?

Calidi Biotherapeutics CEO Eric Poma, Ph.D. will present at the H.C. Wainwright 27th Annual Global Investment Conference to discuss the company’s RedTail platform for delivering genetic medicines to metastatic cancer sites.

When and where is the H.C. Wainwright conference taking place?

The conference is scheduled for September 8-10, 2025, at the Lotte New York Palace Hotel in New York City.

When will the on-demand presentation be available?

The on-demand presentation will be available starting September 5, 2025, at 7:00 AM Eastern Time.

What is Calidi Biotherapeutics’ RedTail platform?

The RedTail platform is an engineered enveloped oncolytic virus designed for systemic delivery that protects the virus from immune clearance, induces tumor lysis, and delivers therapeutic genetic medicines to metastatic cancer sites.

What types of cancer does Calidi’s lead candidate target?

The lead candidate from the RedTail platform targets non-small cell lung cancer, ovarian cancer, and other tumor types with high unmet medical need, and is currently in IND-enabling studies.

What is Calidi Biotherapeutics’ stock symbol?

Calidi Biotherapeutics trades on the NYSE American under the ticker symbol CLDI.

Where can investors find more information about Calidi Biotherapeutics?

Investors can find the latest news and updates in the company’s newsroom at https://ibn.fm/CLDI and view the full press release at https://ibn.fm/85iH4.

What other cancer therapies is Calidi developing besides the RedTail platform?

Calidi is also developing protected virotherapies for intratumoral and localized administration, which are in clinical-stage development for injectable cancer indications.

What is TinyGems and how is it related to this announcement?

TinyGems is a specialized communications platform focused on innovative small-cap and mid-cap companies that published this announcement, and it’s part of the IBN (InvestorBrandNetwork) portfolio that provides distribution services to reach investors and the public.